Assertio to Participate in the Maxim Group Healthcare Virtual Summit on October 15, 2024

FacebookFacebookTwitterTwitterEmailEmailLinkedInLinkedInWhatsAppWhatsAppMessengerMessengerFlipboardFlipboardGmailGmailTelegramTelegramShareShare

LAKE FOREST, Ill., Oct. 11, 2024 (GLOBE NEWSWIRE) — Assertio Holdings, Inc. (“Assertio” or the “Company”) (Nasdaq: ASRT), a pharmaceutical company with comprehensive commercial capabilities offering differentiated products to patients, announced that Brendan O’Grady, Chief Executive Officer, will participate in a fireside chat discussion as part of the Maxim Group 2024 Healthcare Virtual Summit. The fireside chat with Mr. O’Grady, hosted by Maxim Group research analyst Naz Rahman, will occur Tuesday, October 15, 2024 at 1:00 pm Eastern Time.

Investors can register to listen to the event via https://m-vest.com/events/healthcare-10152024.

About Assertio

Assertio is a commercial pharmaceutical company with comprehensive commercial capabilities offering differentiated products to patients. We have built our commercial portfolio through acquisition or licensing of approved products. Our commercial capabilities include marketing through both a sales force and a non-personal promotion model, market access through payor contracting, and trade and distribution. To learn more about Assertio, visit www.assertiotx.com.

Investor Contact

Matt Kreps, Managing Director
Darrow Associates
M: 214-597-8200
mkreps@darrowir.com

Staff

Recent Posts

Surgimate Appoints Jessica Cook as Chief Revenue Officer

NEW YORK--(BUSINESS WIRE)--Surgimate, a leading provider of surgical coordination and scheduling software in the U.S.,…

6 hours ago

Fuse Oncology Announces Partnership With Elekta

Industry vendors team up to support radiation oncology clinics nationwide BOONE, N.C., June 19, 2025…

6 hours ago

CQ fluency Appoints Tameeka Smith as Chief Executive Officer

Tenured healthcare executive to succeed Founder Elisabete Miranda Smith to build on 25-year legacy of…

6 hours ago